➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
AstraZeneca
Express Scripts
McKesson
Medtronic

Last Updated: October 17, 2021

DrugPatentWatch Database Preview

ACETAZOLAMIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Acetazolamide patents expire, and what generic alternatives are available?

Acetazolamide is a drug marketed by Accord Hlthcare, Alembic Pharms Ltd, Cadila, Heritage Pharma, Indicus Pharma, Micro Labs Ltd India, Mylan, Nostrum Labs Inc, Novast Labs, Alra, Appco, Ascot, Breckenridge, Eywa Pharma, Lannett, Mankind Pharma, Novitium Pharma, Rubicon, Strides Pharma, Sun Pharm Industries, Taro, Vangard, Watson Labs, Emcure Pharms Ltd, Hospira, Mylan Asi, Par Sterile Products, West-ward Pharms Int, Xgen Pharms, and Zydus Pharms. and is included in thirty-two NDAs.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide

A generic version of ACETAZOLAMIDE was approved as acetazolamide sodium by WEST-WARD PHARMS INT on February 28th, 1995.

  Try it Free

Drug patent expirations by year for ACETAZOLAMIDE
Drug Prices for ACETAZOLAMIDE

See drug prices for ACETAZOLAMIDE

Recent Clinical Trials for ACETAZOLAMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ji Xunming,MD,PhDPhase 4
Johan VirhammarPhase 2
Swedish Society for Medical ResearchPhase 2

See all ACETAZOLAMIDE clinical trials

Pharmacology for ACETAZOLAMIDE
Medical Subject Heading (MeSH) Categories for ACETAZOLAMIDE

US Patents and Regulatory Information for ACETAZOLAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xgen Pharms ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040784-001 Dec 10, 2008 AP RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Taro ACETAZOLAMIDE acetazolamide TABLET;ORAL 040195-001 May 28, 1997 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Strides Pharma ACETAZOLAMIDE acetazolamide TABLET;ORAL 209734-001 Nov 20, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
AstraZeneca
Express Scripts
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.